TUCSON
520.748.4400
About Us
Professional Staff
Board of Directors
Careers
Contact Us
Frederick Gardner
Cottrell Foundation
Successes
Ventures
Biotechnology
Medical Devices
Other
Historic Investments
Technologies
The CH2 Domain Scaffold – ABDURINS™
Deimmunized Sarcin Ribotoxin
Endotoxin-free ClearColi™ Expression System
Fibronectin Artificial Antibody Scaffold
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Pichia Classic Expression Platform
Pichia GlyoSwitch™ Protein Expression System
Shingles Vaccine Antigen
Ultrasound Tissue Harmonic Imaging
VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
Innovate With Us
News & Events
Home
»
News & Events
»
2022
AustinPx Names Derek Hennecke and Marshall Crew to its Board of Directors
10.18.2022
BioTools Innovator Names GenNext Technologies The 2022 Winner GenNext Technologies Wins the $250,000 Grand Prize at the BioTools Innovator Capstone Event
10.17.2022
Pheon Therapeutics raises $68 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates
10.5.2022
TD2 Announces Dr. Alan Miller as New Chief Medical Officer
10.5.2022
Flagship Biosciences Receives Growth Equity Investment and Acquires Pharma Services Business from Interpace Biosciences
8.31.2022
DisperSol appoints Tim Scott new President and CEO; Company changes name to AustinPx™, Pharmaceutics and Manufacturing
8.22.2022
Kemp Proteins Secures $5M Growth Financing from BroadOak Capital Partners
7.21.2022
Halo Labs Completes $6M Series C Growth Financing
7.11.2022
BioTools Innovator Announces Companies Selected for 2022 Accelerator Cohort
7.6.2022
RCT and Broad Oak Lead Major Investment in Biolog
5.12.2022
Post navigation
←
Older posts
News by Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
From concept
to market
Innovate with us ›